SCHEMBL4726015

SCHEMBL4726015

CCCCCCCCCCCCCCCC(=O)OC(=O)CC(O)C(=O)OC(=O)CCCCCCCCCCCCCCC

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.53
DGKA P23743 1/20 0.52
LMNA P02545 4/20 0.50
KDM4E B2RXH2 1/20 0.50
DUSP3 P51452 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 1/20 0.47
PAM P19021 2/20 0.47
NAAA Q02083 1/20 0.47
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3379305 1.00 MAPT (0.53) MAPTDGKALMNAKDM4EDUSP3
SCHEMBL9723687 1.00 MAPT (0.53) MAPTDGKALMNAKDM4EDUSP3
SCHEMBL28605449 1.00 MAPT (0.53) MAPTDGKALMNAKDM4EDUSP3
SCHEMBL28358120 1.00 MAPT (0.53) MAPTDGKALMNAKDM4EDUSP3
SCHEMBL28005808 1.00 MAPT (0.53) MAPTDGKALMNAKDM4EDUSP3
SCHEMBL20853447 1.00 MAPT (0.53) MAPTDGKALMNAKDM4EDUSP3
SCHEMBL28285143 0.98 MAPT (0.51) MAPTDGKALMNAKDM4EDUSP3
SCHEMBL27796633 0.91 DGKA (0.57) MAPTDGKALMNADUSP3
SCHEMBL9723690 0.88 PAM (0.54) MAPTDGKALMNAKDM4EDUSP3
SCHEMBL9220943 0.88 PAM (0.54) MAPTDGKALMNAKDM4EDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008027063-A1 ANTI-AGING SKIN PREPARATION BLASS JOHN P (US) 2008-03-06 WO claimed
US-20080057088-A1 Anti-aging cream BLASS JOHN P 2008-03-06 US claimed
US-8435547-B2 Krebs cycle intermediate or precursor of Krebs cycle intermediate, pharmaceutically acceptable topical vehicle comprising a mitochondrial fuel or substance that is efficiently convertible to mitochondrial fuel by normal skin cell metabolism; for stimulating mitochondrial activity in skin cells Blass, John P. (US) 2013-05-07 US disclosed
WO-2008027063-A1 ANTI-AGING SKIN PREPARATION BLASS JOHN P (US) 2008-03-06 WO disclosed
US-20080057088-A1 Anti-aging cream BLASS JOHN P 2008-03-06 US disclosed